Amber N Clements

5PUBLICATIONS
31CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 21, 2025
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.

Amber N Clements, Andrea L Casillas, Caitlyn E Flores

|Nov 01, 2024
Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy.

Amber N Clements, Andrea L Casillas, Caitlyn E Flores

|Apr 12, 2023
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.

Corbin C Jensen, Amber N Clements, Hope Liou

|Nov 26, 2022
Targeting PIM Kinases to Improve the Efficacy of Immunotherapy.

Amber N Clements, Noel A Warfel

|Jul 02, 2021
Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors.

Andrea L Casillas, Shailender S Chauhan, Rachel K Toth

Pageof 1